Elemental concentration analysis in prostate tissues using total reflection X-ray fluorescence

Radiation Physics and Chemistry

Volumn 95, Issue , 2014, Pages 62-64

  Leitao R G ^a   Palumbo, A ^a   Souza, P A V R ^a   Pereira, G R ^b   Canellas, C G L ^c   Anjos, M J ^a,c   Nasciutti, L E ^a   Lopes, R T ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Non destructive Testing   (Brazil)

^c FEDERAL UNIVERSITY OF THE STATE OF RIO DE JANEIRO   (Brazil)

Author keywords

Prostate tissue; Synchrotron radiation; Trace elements; X ray fluorescence spectroscopy

Indexed keywords

BENIGN PROSTATE HYPERPLASIA; ELEMENTAL CONCENTRATIONS; MANN-WHITNEY U TEST; PROSTATE TISSUE; SYNCHROTRON RADIATION TECHNIQUES; TOTAL REFLECTION X-RAY FLUORESCENCE; X RAY FLUORESCENCE SPECTROSCOPY; ZINC CONCENTRATION;

DISEASES; ELECTROMAGNETIC WAVE REFLECTION; FLUORESCENCE SPECTROSCOPY; HISTOLOGY; SYNCHROTRON RADIATION; TISSUE; TRACE ELEMENTS; URANIUM; UROLOGY; X RAYS; ZINC;

TISSUE ENGINEERING;

CALCIUM; COPPER; IRON; PHOSPHORUS; POTASSIUM; RUBIDIUM; SULFUR; ZINC;

ADULT; AGED; ARTICLE; BRAZIL; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PROSTATE; PROSTATE CANCER; PROSTATE HYPERTROPHY; RANK SUM TEST; SYNCHROTRON RADIATION; TOTAL REFLECTION X RAY FLUORESCENCE; VERY ELDERLY; X RAY FLUORESCENCE;

EID: 84890120165     PISSN: 0969806X     EISSN: 18790895     Source Type: Journal    
DOI: 10.1016/j.radphyschem.2012.12.044     Document Type: Article

References (14)

1. Banudevi S., Senthilkumar K., Sharmila G., Arunkumar R., Vijayababu M.R., Arunakaran J. Effect of zinc on regulation of insulin-like growth factor signaling in human androgen-independent prostate cancer cells. Clin. Chim. Acta. 2010, 411:172-178.
2. Bernasconi, G., Tajani, A., 1996. Quantitative X-ray Analysis System (QXAS) Software, Package: Documentation Version 1.2. International Atomic Energy Agency, Vienna.
3. Costello L.C., Franklin R.B. Concepts of citrate production and secretion by prostate 1. Metabolic relationships. Prostate 2006, 68:25-46.
4. Franklin R.B., Costello L.C. Zinc as an anti-tumor agent in prostate cancer and in other cancers. Arch. Biochem. Biophys. 2007, 463:211-217.
5. Kirby R.S. The natural history of benign prostatic hyperplasia: what have we learned in the last decade?. Urology 2000, 56:3-6.
6. Kubala-Kukus A., Banas D., Braziewicz J., Góźdź S., Majewska U., Pajek M. Analysis of elemental concentration censored distributions in breast malignant and breast benign neoplasm tissues. Spectrochim. Acta. Part B 2007, 62:695-701.
7. Kwiatek W.M., Banas A., Gajda M., Pawlicki B., Falkenberg G., Cichocki T. Cancerous tissues analyzed by SRIXE. J. Alloys Compd. 2005, 401:173-177.
8. Liping Huang L., Kirschke C.P., Zhang Y. Decreased intracellular zinc in human tumorigenic prostate epithelial cells: a possible role in prostate cancer progression. Cancer Cell Int. 2006, 6:10.
9. Sarafanova A.G., Todorov T.I., Kajdacsy-Ballac A., Grayd M.A., Maciasc V., Centenoa J.A. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry. J. Trace Elem. Med. Biol. 2008, 22:305-314.
10. Vartsky D., Shilstein S., Bercovich A., Huszar M., Breskin A., Chechik R., Korotinsky S., Malnick S.D., Moriel E. Prostatic zinc and prostate specific antigen: an experimental evaluation of their combined diagnostic value. J. Urol. 2003, 170:2258-2262.
11. Yaman M., Atici D., Bakirdere S., Akdeniz I. Comparison of trace metal concentrations in malign and benign human prostate. J. Med. Chem. 2005, 48:630-634.
12. Zaichick V. INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate. Q. J. Nucl. Med. Mol. Imaging 2004, 262:229-234.
13. Zaichick V. Medical elementology as a new scientific discipline. J. Radioanal. Nucl. Chem. 2006, 269:303-309.
14. Zaichick V.Y.E., Sviridova T.V., Zaichick S.V. Zinc in the human prostate gland: normal, hyperplastic and cancerous. Int. Urol. Nephrol. 1997, 29(5):565-574.